McKesson Corporation (NYSE:MCK) shareholders might be concerned after seeing the share price drop 16% in the last quarter. But in stark contrast, the returns over the last half decade have ...
Robert W. Baird analyst Eric Coldwell downgraded the rating on McKesson (MCK – Research Report) to a Hold today, setting a price target of $531.00. Eric Coldwell’s rating is based on a series ...
McKesson (MCK) closed at $488.78 in the latest trading session, marking a -1.95% move from the prior day. This change lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw an upswing of ...
McKesson did not report a suspicious order in the Baltimore area from the time of the settlement until March 2012 — almost four years later. On March 12, 2009, a McKesson official told ...
Baird downgraded medical distributor McKesson (NYSE:MCK) to neutral from outperform on Tuesday, calling the company's plans to conduct an investor event with the sell-side community "unusual." ...